Laserfiche WebLink
<br />temperature of the specimen. The time from urination to temperature measure is critical <br />and in no case shall exceed four (4) minutes. A specimen temperature outside the <br />normal range constitutes a reason to believe that the individual has altered or substituted <br />the specimen. In such case, the driver may volunteer to have his or her oral temperature <br />taken to provide evidence to counter the reason to believe the individual may have <br />altered or substituted the specimen. <br /> <br />Immediately after the specimen is collected, the collection site person shall also inspect <br />the specimen to determine its color and look for any signs of contaminants. Any unusual <br />finding shall be noted on the urine custody and control form. <br /> <br />Whenever there is reason to believe that a driver has altered or substituted the specimen, <br />a second specimen shall be obtained as soon as possible under the direct observation of a <br />same gender collection site person. <br /> <br />Both the driver and the collection site person shall keep the specimen in view at all times <br />prior to its being sealed and labeled. The specimen sball be sealed and labeled in the <br />presence ofthe driver. The collection site person shall place securely on the bottle an <br />identification label which contains the date, the individual specimen number, and any <br />other relevant identifying information. The driver shall initial the identification label on <br />the specimen bottle for the purpose of certifying that it is the specimen collected from <br />him or her. <br /> <br />The collection site person shall enter on the drug testing custody and control form all <br />information identifying the specimen. The collection site person shall sign the drug <br />testing custody and control form certifying that the collection was accomplished <br />according to the applicable federal requirements. <br /> <br />Ifthe initial screening conducted by the laboratory yields a positive result, the result <br />shall be confirmed using gas chromatography/mass spectrometry (GC/MS). <br /> <br />3. Dru2 Test Results. Drug test results are reported directly to the MRO by the <br />testing laboratory. The MRO reports the results to the City's designated contact person. <br />Ifthe results are negative, the City is informed and no further action is necessary. If the <br />test result is confirmed positive, the MRO shall give the driver an opportunity to discuss <br />the test result. The MRO will contact the driver directly, on a confidential basis, to <br />determine whether the person wishes to discuss the positive test result. The MRO must <br />review any medical records supplied by a driver to determine if a confirmed positive test <br />is the result ofthe driver having taken legally prescribed medication. The MRO shall <br />verify and report a positive test result to the City when there is no legitimate medical <br />reason for a positive test result as received from the testing laboratory. <br /> <br />A. MRO Unable to Contact Driver. If after making reasonable efforts <br />and documenting these efforts, the MRO is unable to reach the driver directly, <br />the MRO must contact the designated City contact person, who shall direct the <br />driver to contact the MRO. If the City contact person is unable to contact the <br />driver, the driver will be placed on a temporary medically unqualified status or <br />medical leave. <br /> <br />B. MRO Mav Verify Positive Test. The MRO may verify a test positive <br />without having communicated directly with the driver about the test results <br />under the following circumstances: <br /> <br />page 8 <br />